Full name
BIONANOPLUS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.E - Healthcare
68.31.Z - Real estate brokerage
71.20.A - Food quality testing and analysis
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
86.90.A - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
2022 | 2023 | 2024 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -4,3 | -5,6 | -6,8 | -23 |
Gross profit (loss) | -2,8 | -5,6 | -6,9 | -23,8 |
EBITDA | -4,3 | -5,6 | -6,9 | -23,8 |
Short time liabilities | 85,2 | 0,3 | 0,1 | -70,6 |
Other operating costs | 0 | 0 | 0 | 4566,7 |
Equity capital | 9,7 | 4,2 | 5,6 | 34,9 |
Operating profit (EBIT) | -4,3 | -5,6 | -6,9 | -23,8 |
Assets | 95 | 4,4 | 5,7 | 28,2 |
Net profit (loss) | -2,8 | -5,6 | -6,9 | -23,8 |
Cash | 93,8 | 4,2 | 5,7 | 36,7 |
Liabilities and provisions for liabilities | 85,2 | 0,3 | 0,1 | -70,6 |
Net income from sale | 3,7 | 0 | 0 | 0 |
Working assets | 95 | 4,4 | 5,7 | 28,2 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -28,5 | -133,8 | -122,7 | 11,1 |
Equity capital to total assets | 10,2 | 93,6 | 98,5 | 4,9 |
Gross profit margin | -75,2 | |||
EBITDA Margin | -116,2 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 8432 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 1.1140767335891724 | 15.651636123657227 | 68.10472869873047 | 52,4 |
Net dept to EBITDA | 21.88062858581543 | 0.7489439249038696 | 0.8270484209060669 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane